Early-stage research, including small observational studies and pilot trials, suggests that naltrexone combined with GLP-1 medications may offer additive weight loss benefits by targeting multiple appetite-regulation pathways
In addition, a meta-analysis was performed comparing pancreatitis events and exposure (patient-years) using Comprehensive Meta-Analysis version 2.2.064 (Englewood, NJ, USA), calculating the rate ratios and their 95% CIs, and the p value or difference
She also investigated the impact of genetic mutations underlying neonatal diabetes using CRISPR HDR knockin genome editing in human induced pluripotent stem cell (hiPSC) models and their derivatives.During her PhD, she explored the role of an epigenetic regulator and its molecular machinery in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), now termed metabolic dysfunction-associated steatotic liver disease (MASLD)
Learn more about safe blood sugar management here:
This drug may cause side effects, including nausea/vomiting, diarrhea, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, gas, hair loss, GERD, abdominal distenision, dizziness and low blood pressure
Results Expression of carnitine palmitoyl transferase 1a mRNA in depressed patients The expression of CPT1a mRNA in pathological brain samples of patients that committed suicide with a history of depression and compared non-depressed controls that committed suicide was analyzed by affymetrix analysis (Table 1)
